English
Dr. Lal PathLabs Q2 Results
- BSE: 539524
- NSE: LALPATHLAB
- ISIN: INE600L01024
- Sector: Healthcare Facilities
BSE
1,374.70
-43.70 (-3.08%)
-43.70 (-3.08%)Volume10.59 K
Updated: Fri 23 Jan, 2026 | 15:25:33
NSE
1,377.80-40.10 (-2.83%)
-40.10 (-2.83%)Volume4.30 L
Updated: Fri 23 Jan, 2026 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹730.60 Cr.(10.66%)
- Operating Profit₹183.60 Cr.(9.81%)
- Profit After Tax₹150.60 Cr.(16.56%)
- Operating Margin25.13%(-0.77%)
Note: Comparison is on YoY basis
Quarterly - Dr. Lal PathLabs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 547.00 | 512.10 | 6.82% | 493.00 | 10.95% |
| Depreciation/ Amortization | 40.50 | 34.60 | 17.05% | 35.30 | 14.73% |
| Operating Income | 183.60 | 157.70 | 16.42% | 167.20 | 9.81% |
| Net Income | 150.60 | 132.40 | 13.75% | 129.20 | 16.56% |
| Other Operating Expenses Total | 126.20 | 124.10 | 1.69% | 112.70 | 11.98% |
| Net Income Before Taxes | 203.60 | 181.10 | 12.42% | 183.10 | 11.20% |
| Total Revenue | 730.60 | 669.80 | 9.08% | 660.20 | 10.66% |
| Selling/ General/ Admin Expenses Total | 238.50 | 224.50 | 6.24% | 217.70 | 9.55% |
| Diluted Normalized EPS | 9.01 | 7.98 | 12.86% | 7.74 | 16.34% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.